Interest in antibacterial nanomaterials has surged due to the growing threat of antibiotic-resistant microbes. A particularly promising strategy involves the use of nanomaterials that generate reactive oxygen species upon exposure to light, effectively combating microorganisms. However, a key challenge lies in translating the properties observed at the molecular level to the material as a whole. Researchers at the University of Duisburg-Essen, led by Junior Professor Dr. Anzhela Galstyan, have made significant progress in addressing this challenge. Using fluorescence lifetime microscopy, they visualised the active sites of these materials for the first time, enabling them to establish correlations between activity and material properties. Their findings were recently published in Angewandte Chemie.
The global nano-biotechnology market is on the brink of remarkable growth, driven by the increasing demand for personalized medicine, an aging population, and groundbreaking advancements in drug delivery, diagnostics, and tissue engineering. This rapidly evolving field holds the potential to revolutionize not just healthcare, but also agriculture and energy sectors. As innovation continues to unfold, nano-biotechnology is set to shape a future with more precise, effective, and sustainable solutions, making it a pivotal force in the world of science and technology.
Nanomaterials, substances with at least one dimension in the nanometer range (1 to 100 nanometers), have shown immense potential across various industries due to their unique properties, such as increased strength, enhanced chemical reactivity, and improved electrical conductivity. As research and technological advancements continue to unfold, nanomaterials are becoming a cornerstone in applications spanning from electronics and healthcare to energy and environmental sectors. The global market for nanomaterials is on a robust growth trajectory, driven by the increasing demand for high-performance materials in numerous industries.
This report explores the key drivers, challenges, trends, and growth opportunities within the global nanomaterials market. The market is forecasted to grow at a compound annual growth rate (CAGR) of 14.4%, with the market value expected to rise from US$12.2 billion in 2024 to US$31.3 billion by 2031.
Researchers at the New Jersey Institute of Technology (NJIT) have unveiled a groundbreaking imaging technology called modulated optically computed phase microscopy (M-OCPM), which allows scientists to visualize the interactions between nanoparticles (NPs) and living cells with exceptional clarity and precision. This novel approach aims to advance the development of nanoparticle-based drug delivery systems, which have shown great promise in medical treatments including targeted therapies and vaccines.
Nanoparticles have gained considerable attention as innovative drug delivery vehicles due to their ability to transport therapeutics directly to targeted sites within the body. Understanding how these particles behave at the cellular level is vitally important, particularly how they interact with cells during processes of absorption and release. Unfortunately, traditional imaging techniques often struggle to provide reliable insights about these interactions due to limitations related to resolution and sensitivity.
A team of scientists has developed a groundbreaking approach using specially designed peptides to improve drug formulations. This innovative method significantly enhances anti-tumor efficacy, as demonstrated in leukemia models. The study, published in the journal Chem, was led by researchers at the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) and Memorial Sloan Kettering Cancer Center.
Drug delivery systems often face two critical challenges: poor solubility and inefficient delivery within the body. Many drugs do not dissolve well, making it difficult for them to reach their intended targets. Furthermore, current delivery systems waste a significant portion of the drug during preparation—only 5–10% of the drug is successfully loaded, leading to less effective treatments.
(Nanowerk News) Tiny copper ‘nano-flowers’ have been attached to an artificial leaf to produce clean fuels and chemicals that are the backbone of modern energy and manufacturing.
The researchers, from the University of Cambridge and the University of California, Berkeley, developed a practical way to make hydrocarbons – molecules made of carbon and hydrogen – powered solely by the sun.
The device they developed combines a light absorbing ‘leaf’ made from a high-efficiency solar cell material called perovskite, with a copper nanoflower catalyst, to convert carbon dioxide into useful molecules. Unlike most metal catalysts, which can only convert CO2 into single-carbon molecules, the copper flowers enable the formation of more complex hydrocarbons with two carbon atoms, such as ethane and ethylene — key building blocks for liquid fuels,
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today
Taking center stage is the Application of Nanotechnology in the Satellite Market which stands as a significant area of focus for many stakeholders, given its potential to revolutionize satellite design and functionalities leveraging the power of nanotechnology, replete with possibilities stemming from miniaturization, enhanced material properties and advanced imaging.
What Is The Current Size And Growth Rate Of The Application Of Nanotechnology In The Satellite Market
Promising data reveals that the application of nanotechnology in the satellite market saw steady growth from $6.58 billion in 2024 to $7.02 billion in 2025, delivering a compound annual growth rate (CAGR) of 6.7%. Factors like the miniaturization in satellite design, improved energy efficiency and cost reduction in satellite manufacturing have played a pivotal role in this robust growth.
Forecast data suggests continuation of this positive trajectory, projecting growth to $8.93 billion in 2029 at a CAGR of 6.2%, spurred by the rising adoption of cubesat and smallsat, high-resolution imaging demand, increased space exploration activities and improved satellite power systems.
Harvard University and the Chinese University of Hong Kong researchers have developed a technique that increases the solubility of drug molecules by up to three orders of magnitude. This could be a breakthrough in drug formulation and delivery.
Over 60% of pharmaceutical drug candidates suffer from poor water solubility, which limits their bioavailability and therapeutic viability. Conventional techniques such as particle-size reduction, solid dispersion, lipid-based systems, and mesoporous confinement often have drug-specific limitations, can be costly to implement, and are prone to stability issues.
The newly developed approach addresses these issues by leveraging the competitive adsorption mechanism of drug molecules and water on engineered silica surfaces. It avoids chemical modification of drug molecules or using additional solubilizing agents to achieve solubility, potentially replacing multiple drug delivery technologies.
Ijeoma Uchegbu, Professor of Pharmaceutical Nanoscience at UCL and Co-Founder and CSO of Nanomerics, gave one of this year's keynote presentations at ELRIG Drug Discovery 2024 in London. ELRIG Drug Discovery is Europe's largest conference for the drug discovery community, providing attendees with the thought and industry leaders at the forefront of drug discovery. In her address, Ijeoma Uchegbu showcased how nanoparticles can be used to improve medication adherence, as well as a novel non-addictive pain product that has the potential to address the opioid crisis.